Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test could help tailor breast cancer treatment, potentially sparing some patients stronger drugs
Disease control Not yet recruitingThis study is testing a personalized approach for people with a specific type of early-stage breast cancer. It uses a blood test to check for tiny signs of cancer. Based on the test result, participants either continue standard hormone therapy or add a stronger drug to it. The go…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Blood test could spare women unnecessary radiation after cancer surgery
Knowledge-focused Not yet recruitingThis study aims to see if a blood test that looks for tiny bits of cancer DNA can help doctors decide which patients need radiation after surgery. It will compare outcomes for over 1,000 women with early-stage endometrial cancer who are monitored with the blood test versus those …
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC